Pfizer’s 20-valent pneumococcal conjugate vaccine (PCV20), marketed under the brand name APEXXNAR, has been approved by the Singapore Health Sciences…
Pfizer’s 20-valent pneumococcal conjugate vaccine (PCV20), marketed under the brand name APEXXNAR, has been approved by the Singapore Health Sciences…